Page last updated: 2024-08-18

pyridostigmine bromide and Muscular Dystrophy

pyridostigmine bromide has been researched along with Muscular Dystrophy in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (50.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Bobadilla-Quesada, EJ; Carrera-García, L; Codina, A; Colomer, J; Corbera, J; Cuadras, D; Exposito-Escudero, J; Gallano, P; Gonzalez-Quereda, L; Jimenez-Mallebrera, C; Jou, C; Medina, J; Moya, O; Nascimento, A; Natera-de Benito, D; Ortez, C; Saez, V; Yoldi, ME	1
Bodechtel, G; Mittelbach, F	1

Other Studies

2 other study(ies) available for pyridostigmine bromide and Muscular Dystrophy

Article	Year
Early and long-term effect of the treatment with pyridostigmine in patients with GMPPB-related congenital myasthenic syndrome. Neuromuscular disorders : NMD, 2020, Volume: 30, Issue:9 Topics: Adult; Dystroglycans; Female; Humans; Male; Muscular Dystrophies; Muscular Dystrophies, Limb-Girdle; Myasthenic Syndromes, Congenital; Nucleotidyltransferases; Pyridostigmine Bromide	2020
[On the therapy of muscular diseases]. Munchener medizinische Wochenschrift (1950), 1968, Sep-06, Volume: 110, Issue:36 Topics: Adrenal Cortex Hormones; Anabolic Agents; Cholinesterase Inhibitors; Dermatomyositis; Humans; Immunosuppressive Agents; Mineralocorticoid Receptor Antagonists; Muscular Diseases; Muscular Dystrophies; Myasthenia Gravis; Myositis; Neostigmine; Physical Therapy Modalities; Pyridostigmine Bromide; Vitamin E	1968

Article

Year

Early and long-term effect of the treatment with pyridostigmine in patients with GMPPB-related congenital myasthenic syndrome.

Neuromuscular disorders : NMD, 2020, Volume: 30, Issue:9

Topics: Adult; Dystroglycans; Female; Humans; Male; Muscular Dystrophies; Muscular Dystrophies, Limb-Girdle; Myasthenic Syndromes, Congenital; Nucleotidyltransferases; Pyridostigmine Bromide

2020

[On the therapy of muscular diseases].

Munchener medizinische Wochenschrift (1950), 1968, Sep-06, Volume: 110, Issue:36

Topics: Adrenal Cortex Hormones; Anabolic Agents; Cholinesterase Inhibitors; Dermatomyositis; Humans; Immunosuppressive Agents; Mineralocorticoid Receptor Antagonists; Muscular Diseases; Muscular Dystrophies; Myasthenia Gravis; Myositis; Neostigmine; Physical Therapy Modalities; Pyridostigmine Bromide; Vitamin E

1968